Sarepta Therapeutics (NASDAQ:SRPT) reported a second fatality from acute liver failure in a patient treated with its gene ...

U.S. stock futures are pointing higher as investors monitor geopolitical tensions ahead of a holiday-shortened week; Victoria's Secret shares are rising in premarket trading on a ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.